nodes	percent_of_prediction	percent_of_DWPC	metapath
Ridogrel—TBXA2R—Small Ligand GPCRs—CNR2—pancreatic cancer	0.0661	0.0662	CbGpPWpGaD
Ridogrel—TBXA2R—Small Ligand GPCRs—CNR1—pancreatic cancer	0.0474	0.0475	CbGpPWpGaD
Ridogrel—TBXAS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—pancreatic cancer	0.0326	0.0326	CbGpPWpGaD
Ridogrel—TBXAS1—Eicosanoid Synthesis—PTGS2—pancreatic cancer	0.0212	0.0212	CbGpPWpGaD
Ridogrel—TBXAS1—Prostaglandin Synthesis and Regulation—PTGS2—pancreatic cancer	0.0177	0.0177	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—PRLHR—pancreatic cancer	0.0143	0.0143	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (q) signalling events—CCKBR—pancreatic cancer	0.014	0.014	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—CCKBR—pancreatic cancer	0.0125	0.0125	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—PRLHR—pancreatic cancer	0.0122	0.0122	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—SSTR3—pancreatic cancer	0.0121	0.0122	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (q) signalling events—GAST—pancreatic cancer	0.012	0.0121	CbGpPWpGaD
Ridogrel—TBXAS1—Arachidonic acid metabolism—PTGS2—pancreatic cancer	0.0118	0.0118	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—SSTR1—pancreatic cancer	0.0116	0.0117	CbGpPWpGaD
Ridogrel—TBXA2R—Thromboxane A2 receptor signaling—PIK3CG—pancreatic cancer	0.0114	0.0115	CbGpPWpGaD
Ridogrel—TBXA2R—Thromboxane A2 receptor signaling—EGF—pancreatic cancer	0.0113	0.0113	CbGpPWpGaD
Ridogrel—TBXA2R—Signal amplification—SRC—pancreatic cancer	0.0113	0.0113	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—SSTR2—pancreatic cancer	0.0112	0.0112	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (q) signalling events—CCK—pancreatic cancer	0.0109	0.0109	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—CCKBR—pancreatic cancer	0.0108	0.0108	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—pancreatic cancer	0.0108	0.0108	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (q) signalling events—CCKAR—pancreatic cancer	0.0104	0.0104	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—SSTR3—pancreatic cancer	0.0104	0.0104	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—SSTR1—pancreatic cancer	0.00997	0.00998	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—PPY—pancreatic cancer	0.00978	0.00979	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—CCK—pancreatic cancer	0.00973	0.00975	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—SSTR2—pancreatic cancer	0.0096	0.00961	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—pancreatic cancer	0.00933	0.00934	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—PRLHR—pancreatic cancer	0.00931	0.00933	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CCKBR—pancreatic cancer	0.00927	0.00928	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—CNR2—pancreatic cancer	0.0082	0.00821	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—CCKAR—pancreatic cancer	0.00807	0.00808	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—SSTR3—pancreatic cancer	0.00792	0.00793	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—SSTR1—pancreatic cancer	0.00759	0.0076	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—PPY—pancreatic cancer	0.00745	0.00746	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (q) signalling events—GCG—pancreatic cancer	0.00735	0.00736	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—SSTR2—pancreatic cancer	0.00731	0.00732	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatic cancer	0.00721	0.00722	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CCKBR—pancreatic cancer	0.00706	0.00707	CbGpPWpGaD
Ridogrel—TBXA2R—Thromboxane A2 receptor signaling—SRC—pancreatic cancer	0.00703	0.00704	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatic cancer	0.00702	0.00703	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (q) signalling events—AGTR1—pancreatic cancer	0.00701	0.00702	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatic cancer	0.00691	0.00692	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—pancreatic cancer	0.00657	0.00658	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—pancreatic cancer	0.00627	0.00628	CbGpPWpGaD
Ridogrel—TBXA2R—Thromboxane A2 receptor signaling—EGFR—pancreatic cancer	0.00616	0.00617	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—IFNA5—pancreatic cancer	0.00611	0.00612	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—CNR1—pancreatic cancer	0.00588	0.00589	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PPP2R5B—pancreatic cancer	0.00577	0.00578	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—SCT—pancreatic cancer	0.00575	0.00576	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CCK—pancreatic cancer	0.00549	0.0055	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—SST—pancreatic cancer	0.00546	0.00547	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—AGTR1—pancreatic cancer	0.00542	0.00543	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CNR2—pancreatic cancer	0.00535	0.00536	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—GLP1R—pancreatic cancer	0.00535	0.00536	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CCKAR—pancreatic cancer	0.00526	0.00527	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatic cancer	0.00504	0.00505	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—SHH—pancreatic cancer	0.0048	0.0048	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PRLHR—pancreatic cancer	0.00478	0.00479	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—IAPP—pancreatic cancer	0.00474	0.00474	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—AGTR1—pancreatic cancer	0.00464	0.00465	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—PTHLH—pancreatic cancer	0.00455	0.00455	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—PTCH1—pancreatic cancer	0.00455	0.00455	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—SSTR3—pancreatic cancer	0.00447	0.00448	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GDI2—pancreatic cancer	0.00438	0.00439	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GDI1—pancreatic cancer	0.00438	0.00439	CbGpPWpGaD
Ridogrel—TBXA2R—Thromboxane A2 receptor signaling—AKT1—pancreatic cancer	0.00437	0.00438	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—SSTR1—pancreatic cancer	0.00429	0.0043	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (12/13) signalling events—PIK3CA—pancreatic cancer	0.00423	0.00424	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PPY—pancreatic cancer	0.00421	0.00421	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—SST—pancreatic cancer	0.00416	0.00417	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—SSTR2—pancreatic cancer	0.00413	0.00414	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—SSTR3—pancreatic cancer	0.00406	0.00407	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CCKBR—pancreatic cancer	0.00399	0.00399	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PRSS1—pancreatic cancer	0.00393	0.00393	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—SSTR1—pancreatic cancer	0.0039	0.0039	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CNR1—pancreatic cancer	0.00384	0.00384	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PPY—pancreatic cancer	0.00382	0.00383	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	0.00382	0.00382	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	0.00377	0.00378	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—SSTR2—pancreatic cancer	0.00375	0.00376	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—GCG—pancreatic cancer	0.00371	0.00371	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CCKBR—pancreatic cancer	0.00362	0.00363	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—AGTR1—pancreatic cancer	0.00354	0.00354	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—CD44—pancreatic cancer	0.00346	0.00346	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—GAST—pancreatic cancer	0.00343	0.00343	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ARG2—pancreatic cancer	0.0034	0.00341	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	0.00336	0.00336	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—IFNA1—pancreatic cancer	0.00335	0.00335	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—SCT—pancreatic cancer	0.00325	0.00326	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—IFNA2—pancreatic cancer	0.00312	0.00312	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—GAST—pancreatic cancer	0.00311	0.00312	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CCK—pancreatic cancer	0.0031	0.00311	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CNR2—pancreatic cancer	0.00302	0.00303	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—GLP1R—pancreatic cancer	0.00302	0.00303	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—TYMP—pancreatic cancer	0.00297	0.00298	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CCKAR—pancreatic cancer	0.00297	0.00298	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—SCT—pancreatic cancer	0.00295	0.00296	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	0.00293	0.00293	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PRLHR—pancreatic cancer	0.00282	0.00283	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CCK—pancreatic cancer	0.00282	0.00282	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CNR2—pancreatic cancer	0.00274	0.00275	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—GLP1R—pancreatic cancer	0.00274	0.00275	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CCKAR—pancreatic cancer	0.0027	0.0027	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—IAPP—pancreatic cancer	0.00268	0.00268	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ZNRF3—pancreatic cancer	0.00265	0.00266	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ACVR1B—pancreatic cancer	0.00265	0.00266	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PTHLH—pancreatic cancer	0.00257	0.00257	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—SHH—pancreatic cancer	0.00246	0.00247	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.00245	0.00246	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—IAPP—pancreatic cancer	0.00243	0.00243	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SSTR3—pancreatic cancer	0.0024	0.0024	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—DTX1—pancreatic cancer	0.0024	0.0024	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GLP1R—pancreatic cancer	0.0024	0.0024	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—DPYD—pancreatic cancer	0.00236	0.00236	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—SST—pancreatic cancer	0.00235	0.00235	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	0.00234	0.00235	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PTCH1—pancreatic cancer	0.00233	0.00234	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PTHLH—pancreatic cancer	0.00233	0.00234	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	0.00231	0.00231	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SSTR1—pancreatic cancer	0.0023	0.0023	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	0.00228	0.00229	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PPY—pancreatic cancer	0.00226	0.00226	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—SLC2A2—pancreatic cancer	0.00224	0.00224	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SSTR2—pancreatic cancer	0.00222	0.00222	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.00222	0.00222	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PLAU—pancreatic cancer	0.00221	0.00222	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CNR1—pancreatic cancer	0.00217	0.00217	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CCKBR—pancreatic cancer	0.00214	0.00214	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.00214	0.00214	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—SST—pancreatic cancer	0.00213	0.00214	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.00213	0.00213	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	0.0021	0.0021	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	0.0021	0.0021	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—GCG—pancreatic cancer	0.0021	0.0021	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (q) signalling events—PIK3CA—pancreatic cancer	0.00204	0.00204	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GLI1—pancreatic cancer	0.00201	0.00201	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—DTX4—pancreatic cancer	0.00201	0.00201	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—AGTR1—pancreatic cancer	0.002	0.002	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	0.00198	0.00199	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CNR1—pancreatic cancer	0.00197	0.00197	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PIK3CG—pancreatic cancer	0.00197	0.00197	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NRP1—pancreatic cancer	0.00196	0.00196	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PPP2R5B—pancreatic cancer	0.00196	0.00196	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.00195	0.00195	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—EGF—pancreatic cancer	0.00195	0.00195	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—GCG—pancreatic cancer	0.0019	0.00191	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HEY2—pancreatic cancer	0.00188	0.00189	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GAST—pancreatic cancer	0.00184	0.00184	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	0.00182	0.00183	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—AGTR1—pancreatic cancer	0.00182	0.00182	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	0.00178	0.00179	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SCT—pancreatic cancer	0.00174	0.00175	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HEY1—pancreatic cancer	0.00174	0.00175	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CD44—pancreatic cancer	0.00173	0.00174	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PIK3CD—pancreatic cancer	0.00173	0.00173	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.0017	0.0017	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	0.00169	0.00169	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.00168	0.00168	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CCK—pancreatic cancer	0.00166	0.00167	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GCG—pancreatic cancer	0.00166	0.00166	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CNR2—pancreatic cancer	0.00162	0.00162	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GLP1R—pancreatic cancer	0.00162	0.00162	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CXCL8—pancreatic cancer	0.00162	0.00162	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CCKAR—pancreatic cancer	0.0016	0.0016	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—STK11—pancreatic cancer	0.00156	0.00156	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—JAG2—pancreatic cancer	0.00155	0.00155	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MEN1—pancreatic cancer	0.00152	0.00153	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PIK3CB—pancreatic cancer	0.00151	0.00151	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	0.00147	0.00147	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	0.00146	0.00146	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SHH—pancreatic cancer	0.00145	0.00146	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NOTCH4—pancreatic cancer	0.00145	0.00145	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IAPP—pancreatic cancer	0.00144	0.00144	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PTHLH—pancreatic cancer	0.00138	0.00138	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PTCH1—pancreatic cancer	0.00138	0.00138	CbGpPWpGaD
Ridogrel—Niflumic Acid—PTGS2—pancreatic cancer	0.00136	1	CrCbGaD
Ridogrel—TBXAS1—Metabolism—TYMS—pancreatic cancer	0.00134	0.00135	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SST—pancreatic cancer	0.00126	0.00126	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.00124	0.00125	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—JAG1—pancreatic cancer	0.00123	0.00124	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NOTCH3—pancreatic cancer	0.00123	0.00123	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—SRC—pancreatic cancer	0.00121	0.00121	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—VEGFA—pancreatic cancer	0.00118	0.00118	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CNR1—pancreatic cancer	0.00116	0.00117	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—NRAS—pancreatic cancer	0.00116	0.00116	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PIK3CG—pancreatic cancer	0.00113	0.00113	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GCG—pancreatic cancer	0.00112	0.00113	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.00109	0.00109	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—APOE—pancreatic cancer	0.00109	0.00109	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—TGFB1—pancreatic cancer	0.00108	0.00108	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—AGTR1—pancreatic cancer	0.00107	0.00107	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—STK11—pancreatic cancer	0.00106	0.00106	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	0.00103	0.00104	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—KRAS—pancreatic cancer	0.001	0.001	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000993	0.000994	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PIK3CG—pancreatic cancer	0.000987	0.000988	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000953	0.000954	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PPARG—pancreatic cancer	0.000952	0.000953	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SMAD4—pancreatic cancer	0.000926	0.000927	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PIK3CA—pancreatic cancer	0.000919	0.000921	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000916	0.000917	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HES1—pancreatic cancer	0.000904	0.000905	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—TP53—pancreatic cancer	0.000889	0.000891	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PIK3CD—pancreatic cancer	0.000867	0.000868	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000865	0.000867	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—HRAS—pancreatic cancer	0.000851	0.000852	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CXCL8—pancreatic cancer	0.000832	0.000833	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TERT—pancreatic cancer	0.000792	0.000793	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HIF1A—pancreatic cancer	0.000757	0.000758	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PIK3CB—pancreatic cancer	0.000756	0.000757	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TSC2—pancreatic cancer	0.000755	0.000756	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—AKT1—pancreatic cancer	0.000751	0.000752	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PTGS2—pancreatic cancer	0.000749	0.00075	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—APOE—pancreatic cancer	0.000739	0.00074	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—KDR—pancreatic cancer	0.000724	0.000725	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NFKBIA—pancreatic cancer	0.000689	0.00069	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NOTCH1—pancreatic cancer	0.000682	0.000683	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PIK3CG—pancreatic cancer	0.000667	0.000668	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—NRAS—pancreatic cancer	0.000667	0.000668	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—EGF—pancreatic cancer	0.00066	0.00066	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PTEN—pancreatic cancer	0.000653	0.000654	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—EGFR—pancreatic cancer	0.000608	0.000609	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PIK3CD—pancreatic cancer	0.000587	0.000587	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000581	0.000582	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—KRAS—pancreatic cancer	0.000574	0.000575	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000528	0.000528	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PIK3CB—pancreatic cancer	0.000511	0.000512	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CXCL8—pancreatic cancer	0.000491	0.000492	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—HRAS—pancreatic cancer	0.000488	0.000489	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—AKT1—pancreatic cancer	0.000475	0.000475	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CASP3—pancreatic cancer	0.00047	0.000471	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PIK3CA—pancreatic cancer	0.000461	0.000461	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CCND1—pancreatic cancer	0.000458	0.000458	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CTNNB1—pancreatic cancer	0.000453	0.000454	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MMP9—pancreatic cancer	0.000444	0.000445	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PTEN—pancreatic cancer	0.000442	0.000442	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—AKT1—pancreatic cancer	0.000431	0.000432	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SRC—pancreatic cancer	0.00041	0.00041	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—VEGFA—pancreatic cancer	0.000399	0.0004	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—STAT3—pancreatic cancer	0.000395	0.000396	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NRAS—pancreatic cancer	0.000394	0.000395	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—AKT1—pancreatic cancer	0.000376	0.000377	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MYC—pancreatic cancer	0.000367	0.000368	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TGFB1—pancreatic cancer	0.000366	0.000367	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—EGFR—pancreatic cancer	0.000359	0.00036	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—KRAS—pancreatic cancer	0.000339	0.00034	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PIK3CA—pancreatic cancer	0.000312	0.000312	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TP53—pancreatic cancer	0.000301	0.000302	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HRAS—pancreatic cancer	0.000288	0.000289	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—AKT1—pancreatic cancer	0.000255	0.000255	CbGpPWpGaD
